Share Name Share Symbol Market Type Share ISIN Share Description
Integumen LSE:SKIN London Ordinary Share GB00BYWJ6269 ORD 0.01P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 0.44p 0 08:00:00
Bid Price Offer Price High Price Low Price Open Price
0.43p 0.45p 0.44p 0.44p 0.44p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
  0.24 -9.58 5.80 0.1 1.2

Integumen (SKIN) Latest News

More Integumen News
Integumen Takeover Rumours

Integumen (SKIN) Share Charts

1 Year Integumen Chart

1 Year Integumen Chart

1 Month Integumen Chart

1 Month Integumen Chart

Intraday Integumen Chart

Intraday Integumen Chart

Integumen (SKIN) Discussions and Chat

Integumen (SKIN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Integumen trades in real-time

Integumen (SKIN) Top Chat Posts

DateSubject
21/10/2018
09:20
Integumen Daily Update: Integumen is listed in the sector of the London Stock Exchange with ticker SKIN. The last closing price for Integumen was 0.44p.
Integumen has a 4 week average price of 0.42p and a 12 week average price of 0.35p.
The 1 year high share price is 2.88p while the 1 year low share price is currently 0.35p.
There are currently 263,608,327 shares in issue and the average daily traded volume is 4,651 shares. The market capitalisation of Integumen is £1,159,876.64.
22/9/2018
14:33
jimduggen: Goodluck gj brandon. Please keep dilution to a minimum and bring some value back to the share price asap. I am sure you will succeed. Keep your investors happy and well informed.
17/7/2018
14:05
gjbrandon: Buywell3. Mentioned above Alltracel spent £22 and 6 years bringing a range of wound care and skin care products to the market. Integumen had already completed all of that and were available for a valuation of £2m. Myself and my Chief Of Operations had to keep under 29% to avoid triggering a Reverse Takeover of Integumen. Cellulac's last transaction and funding round valuation in 2015 was £15m. Since then we concluded the signing of a 5-year offtake agreement for $36m and completed the commercial scale production of Omega 3 at a partner site in UK. These are documented on the Cellulac website. The share price of Cellulac at the last round was £1.00. The shares for Cellulac were swapped for Integumen shares at $0.50. This is public information. However we felt that agreement had been made at a higher valuation of Integumen, which we believed was fair, so we lowered the Cellulac share price, pro-rata to what had been agreed was fair value.
06/4/2017
14:34
mulligut: Rivaldo I am not a day trader so none of that particularly causes me any major concern. This is another share just like any other and hopefully based on what was done with Venn their management can drive value in the long term. I would expect that a decent newsflow regime for breakthrough products and distribution agreements will do a good bit for the share price. Long term it remains a very small part of my portfolio.
Integumen share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20181021 17:15:59